GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma

Immunotherapy based on immune checkpoint inhibitors (ICIs) is considered to be a promising treatment for stomach adenocarcinoma (STAD), but only a minority of patients benefit from it. It is believed that the poor therapeutic efficacy is attributed to the complex tumor immune microenvironment (TIM)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Lin, Chen, Shuming, Liu, Jianyong, Li, He, Zhao, Hu, Zheng, Chunhua, Zhang, Yawei, Huang, Hancong, Huang, Junjie, Wang, Bing, Lin, Chengzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132901/
https://www.ncbi.nlm.nih.gov/pubmed/37124060
http://dx.doi.org/10.1155/2023/7123568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132901/
https://www.ncbi.nlm.nih.gov/pubmed/37124060
http://dx.doi.org/10.1155/2023/7123568

Ejemplares similares